tetraethylammonium has been researched along with Anemia, Sickle Cell in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohnishi, ST | 1 |
| Horiuchi, KY | 1 |
| Horiuchi, K | 1 |
1 other study available for tetraethylammonium and Anemia, Sickle Cell
| Article | Year |
|---|---|
The mechanism of in vitro formation of irreversibly sickled cells and modes of action of its inhibitors.
Topics: Adenosine Triphosphate; Adult; Anemia, Sickle Cell; Calcium; Cell Separation; Chlorpromazine; Erythr | 1986 |